MREFX | VEURX | MREFX / VEURX | |
Total Expense Ratio | 1.40 | 0.24 | 583% |
Annual Report Gross Expense Ratio | 1.92 | 0.24 | 800% |
Fund Existence | 23 years | 35 years | - |
Gain YTD | 8.312 | 27.246 | 31% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 115M | 35.1B | 0% |
Annual Yield % from dividends | 2.40 | 2.76 | 87% |
Returns for 1 year | 3.61 | 17.19 | 21% |
Returns for 3 years | 62.02 | 67.50 | 92% |
Returns for 5 years | 40.85 | 52.64 | 78% |
Returns for 10 years | 50.61 | 60.33 | 84% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RSPH | 30.14 | 0.20 | +0.67% |
Invesco S&P 500® Equal Wt Hlth Care ETF | |||
XPH | 48.20 | 0.19 | +0.40% |
SPDR® S&P Pharmaceuticals ETF | |||
RMIF | 24.94 | 0.05 | +0.21% |
LHA Risk-Managed Income ETF | |||
YFYA | 9.88 | 0.01 | +0.05% |
Yields for You Strategy A ETF | |||
SPEM | 47.05 | -0.06 | -0.13% |
SPDR® Portfolio Emerging Markets ETF |